COMPANIES COVERED
CSL BehringDownload FREE Report Sample
Download Free sampleImmune thrombocytopenia (ITP) is a bleeding disorder caused by thrombocytopenia not associated with a systemic disease. Typically, it is chronic in adults, but it is usually acute and self-limited in children. Spleen size is normal in the absence of another underlying condition.
Immune Thrombocytopenia Treatment Market contains market size and forecasts of Immune Thrombocytopenia Treatment in Global, including the following market information:
Global Immune Thrombocytopenia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Immune Thrombocytopenia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immune Thrombocytopenia Treatment include CSL Behring, Amgen, F.Hoffmann-La Roche, Kyowa Hakko Kirin, Rigel Pharmaceuticals, Shionogi, Dova Pharmaceuticals, Novartis and Shire, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Immune Thrombocytopenia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immune Thrombocytopenia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Immune Thrombocytopenia Treatment Market Segment Percentages, by Type, 2021 (%)
Corticosteroids
Intravenous Immunoglobulin (IVIG)
Anti-D Immunoglobulin
Thrombopoietin Receptor Agonist (TPO-RA)
Others
Global Immune Thrombocytopenia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Immune Thrombocytopenia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals and Clinics
Research and Academic Institutes
Others
Global Immune Thrombocytopenia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Immune Thrombocytopenia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immune Thrombocytopenia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Immune Thrombocytopenia Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL Behring
Amgen
F.Hoffmann-La Roche
Kyowa Hakko Kirin
Rigel Pharmaceuticals
Shionogi
Dova Pharmaceuticals
Novartis
Shire
Ligand Pharmaceuticals
GSK
Grifols Biologicals
Jiangsu Hengrui Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy